http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013104459-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2013104459-A
titleOfInvention CARBOXAMIDE COMPOUNDS AND THEIR APPLICATION AS CALPAIN INHIBITORS
abstract 1. The carboxamide compound of the formula I where R denotes hydrogen, CC-alkyl, CC-alkenyl, CC-alkynyl, where the last 3 radicals mentioned may be partially or fully halogenated and / or have 1, 2 or 3 substituents R, CC-cycloalkyl, CC-cycloalkyl -CC-alkyl, where the CH group in the cycloalkyl fragment of the last two radicals mentioned may be substituted by O, NH, or S, or two adjacent C atoms may form a double bond, where the cycloalkyl fragment may additionally have 1, 2, 3 or 4 R radicals, aryl, hetaryl, aryl-CC-alkyl, aryl-CC-alkenyl, hetaryl-CC- lkil or hetaryl-C-C-alkenyl, where aryl and hetaryl in the last 6 radicals mentioned may be unsubstituted or have 1, 2, 3 or 4 identical or different radicals R; where R is independently selected from OH, SH, COOH, CN, OCHCOOH, CC-alkoxy, CC-haloalkoxy, CC-cycloalkyloxy, CC-alkylthio, CC-haloalkylthio, COOR, CONRR, SONRR, -NR-SO-R, NR —CO — R, SO — R, NRR, R are independently selected from OH, SH, COOH, CN, OCHCOOH, halogen, phenyl, which optionally has 1, 2 or 3 substituents R, or CC-alkyl, CC-alkoxy , CC-alkylthio, where the alkyl moieties in the last 3 mentioned substituents can be partially or fully halogenated and / or have 1, 2 or 3 substituents R, COOR, CONRR, SONRR, NR-SO-R, NR-CO-R, SO -R, NRR, where, apart from this, two R-radicals can together form C- A C alkylene group, or 2 R radicals bonded to adjacent C cycloalkyl atoms, can form together with the carbon atoms to which they are attached, also a benzene ring, R is independently selected from OH, SH, halogen, NO, NH, CN, CF , CHF, CHF, O-CF, O-CHF, O-CHF, COOH, OCHCOOH, CC-alkyl, CC-alkoxy, CC-alkoxy-CC-alkyl, CC-alkylthio, where the alkyl moieties in the last 4 mentioned substituents may would�
priorityDate 2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409092530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73909
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ9P745
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BD32
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466865624
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ9NSP1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R8Z2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PT49
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27730
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A0R4IYF1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6X1Q9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MWT5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37232
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9I5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YYU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A1A6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1MKE9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BLE5

Total number of triples: 64.